Steve Lefar is listed as a director on 4 SEC Form D filings by 2 issuers between Feb 2020 and Sep 2023: Third Eye Health, Inc. (Chicago, IL — other health care — 2023; $7.25M reported sold to 30 investors) and Emerging Therapy Solutions, Inc. (Bloomington, MN — other health care — 2020–2021; $6M reported sold to 5 investors).
What this means 2 separate companies raised money with this person listed as director, over about 3 years. Across those companies the filings report $13.3M sold in total.
Listed alongside David McLean (3 shared filings), J. Matthew Mackowski (3 shared filings), Jeanette Welsh (3 shared filings), Kevin Roche (3 shared filings), Ravi Nalliah (3 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Steve. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Steve Lefar and found 2 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Steve Lefar" (MD) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.